Alexion's Acquisition of Synageva
Scroll to keep reading
Matthew Hurd, Legal counsel to Synageva
Alexion Pharmaceuticals will buy rival Synageva BioPharma in an $8.4 billion cash-and-stock deal that will bolster Alexion’s business in treatments for rare diseases.
Alexion’s takeover offer is aggressive: It will pay $115 in cash and 0.6581 Alexion shares for each share of Synageva, amounting to $230 in cash and stock.
FinanceCaution typified by the recession era still prevails, says American Express
LegalNearly three quarters of businesses (73%) have not started their mandatory energy audits to comply with the new ESOS legislation by the deadline of 5 December 2015.
LegalBusiness disagreements happen more often than many owners expect. When they cannot be resolved privately, they can turn into formal legal battles. At that point, having trusted counsel for corporate litigation matters becomes critical. How Corporate Litigation
FinanceCraig James, CEO at Neopay, discusses the potential impact and implications of a Brexit on the future development of this sector.
InnovationEnabling organisations through its suite of pioneering management systems, IQMS Australasia, offers a highly refreshing approach when it comes to management solutions.
NewsCitizenship signifies a bond, a mutual pact between an individual and a nation. Historically, it has been the culmination of a journey, often marked by years of residency, cultural assimilation, or ancestral ties. Yet, in a world rapidly evolving, the concept
M&AFrench chemicals group Novacap, which is backed by Ardian, has agreed to acquire CU Chemie Uetikon, a Germany-based maker of pharmaceutical substances. The seller is Equistone Partners Europe.
NewsImagine your life derailed in a car accident. At first, the injuries seem manageable – a strained back, some whiplash. Yet, weeks later, the pain intensifies and you’re missing work. Then comes the stack of medical bills, each higher than the last.
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have a number of unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.
